Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRESENT
2024-513801-30-00Phase 3Authorised
- Sponsor
- CHRU Tours
- Start
- Jul 2025
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of phenoxymethylpenicillin in erysipelas (2 arms), sponsored by CHRU Tours. Planned start Jul 2025; status: authorised.
02
Drugs
phenoxymethylpenicillin
03
Conditions
erysipelas
Beyond the preview
Go deeper on 2024-513801-30-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513801-30-00.